NCT04848623 Identification of Vocal Biomarkers to Monitor the Health of People With a Chronic Disease
| NCT ID | NCT04848623 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Luxembourg Institute of Health |
| Condition | Chronic Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 50,000 participants |
| Start Date | 2021-06-26 |
| Primary Completion | 2026-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50,000 participants in total. It began in 2021-06-26 with a primary completion date of 2026-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The CoLive Voice research project aims to identify vocal biomarkers of severe conditions and frequent health symptoms. The project is based on digital technologies and statistical algorithms. This is an international anonymous survey where vocal recordings are collected simultaneously with large validated clinical and epidemiological data, in the context of various chronic diseases or frequent health symptoms in the general population.
Eligibility Criteria
Inclusion Criteria: * Adolescents and adults \> 15 years * With or without health conditions * From all countries Exclusion Criteria: * Children \< 15 years
Contact & Investigator
Guy Fagherazzi, PhD
PRINCIPAL INVESTIGATOR
LIH
Frequently Asked Questions
Who can join the NCT04848623 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, studying Chronic Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04848623 currently recruiting?
Yes, NCT04848623 is actively recruiting participants. Contact the research team at aurelie.fischer@lih.lu for enrollment information.
Where is the NCT04848623 trial being conducted?
This trial is being conducted at Luxembourg, Luxembourg.
Who is sponsoring the NCT04848623 clinical trial?
NCT04848623 is sponsored by Luxembourg Institute of Health. The principal investigator is Guy Fagherazzi, PhD at LIH. The trial plans to enroll 50,000 participants.